BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medicine by Design - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Medicine by Design
X-ORIGINAL-URL:https://mbd.ccrm.ca
X-WR-CALDESC:Events for Medicine by Design
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230126T140000
DTEND;TZID=America/Toronto:20230126T150000
DTSTAMP:20260405T165012
CREATED:20230104T163518Z
LAST-MODIFIED:20230120T180222Z
UID:18141-1674741600-1674745200@mbd.ccrm.ca
SUMMARY:Conversations in Convergence: Targeting protein membranes in disease
DESCRIPTION:Join us for our Conversations in Convergence series\, which features interactive discussions between Medicine by Design researchers who study similar questions using different approaches. \nRegister now\n\nSpeakers \nVineeth Raveendran\, PhD Candidate\, Melanie Woodin lab\, Department of Cell & Systems Biology\, University of Toronto \nEnhancing potassium-chloride cotransporter-2 (KCC2) function in neurons by targeting protein-protein interactions \nVineeth Raveendran is a PhD candidate in Melanie Woodin’s lab and is working on enhancing potassium-chloride cotransporter-2 (KCC2) function in neurons by targeting protein-protein interactions (PPI). Vineeth graduated from the Indian Institute of Science Education and Research-Kolkata (IISER-K) with a Bachelor of Science-Master of Science (BS-MS) dual degree\, majoring in Biological Sciences. His master’s degree research focused on the role of gap junction proteins (connexins) in maintaining neural homeostasis and myelination. In the Woodin Lab\, he has validated PPI inhibitor peptides that can increase KCC2 expression and function\, which is essential for maintaining synaptic inhibition in adult neurons. \n\nMichael Garton\, Assistant Professor\, Institute of Biomedical Engineering\, University of Toronto\, and Canada Research Chair\, Synthetic Biology. \nOvercoming barriers to integrating synthetic biology with regenerative medicine\n \nMichael Garton is an Assistant Professor in the Institute of Biomedical Engineering at the University of Toronto and the Canada Research Chair in synthetic biology. He completed his undergraduate education in chemistry and PhD in computational biology at the University of Nottingham\, U.K. He then moved to Canada for postdoctoral fellowships at The Hospital for Sick Children and University of Toronto\, which allowed him to develop expertise in protein design. He set up his own lab in 2019\, focused on protein design in the context of cell and gene therapy. \n\nAbout Conversations in Convergence\n\nThe goal is to foster cross-disciplinary discussions in support of convergence\, which is the integration of approaches from engineering\, science\, medicine and other fields to expand knowledge and spark innovation. The researchers will discuss how their unique perspectives\, knowledge and ideas inform their work\, and how their diverse approaches intersect and complement one another to advance regenerative medicine. \n 
URL:https://mbd.ccrm.ca/event/conversations-in-convergence/
LOCATION:Donnelly Centre for Cellular and Biomolecular Research\, Red Room\, 160 College Street\, Toronto\, Ontario\, M5S 3E1\, Canada
CATEGORIES:Other Events
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220929T150000
DTEND;TZID=America/Toronto:20220929T160000
DTSTAMP:20260405T165012
CREATED:20220817T163705Z
LAST-MODIFIED:20220921T201635Z
UID:18120-1664463600-1664467200@mbd.ccrm.ca
SUMMARY:Conversations in Convergence: Kristin Hope\, PhD\, and Roshane Frances\, PhD
DESCRIPTION:Note: We are excited to transition Conversations in Convergence from a virtual to an in-person event\, providing more opportunity for networking and potential collaboration.  \nJoin us for our Conversations in Convergence series\, which features interactive discussions between Medicine by Design researchers who study similar questions using different approaches. \nThe theme of this conversation will be\, Targeted approaches to improving cell function for therapy. \nRegister Now\n\nSpeakers \nKristin Hope\, PhDSenior Scientist\, Princess Margaret Cancer Centre\, University Health Network\, and Associate Professor\, Department of Medical Biophysics\, University of Toronto \nHarnessing post-transcriptional circuitries to maximize the therapeutic potential of hematopoietic stem cells \nKristin Hope obtained her PhD from the University of Toronto studying leukemic stem cells in the department of Molecular and Medical Genetics and followed this with a Post-doctoral Fellowship in stem cell functional genetics at the Université de Montreal. Dr. Hope began her independent research program as an Assistant Professor at McMaster University in 2010 and was recruited in 2020 by the Princess Margaret Cancer Centre\, University Health Network where she is a Senior Scientist and holds an Associate Professorship in the Department of Medical Biophysics at the University of Toronto. Dr. Hope also holds an Ontario Institute for Cancer Research Investigator Award and is a Medicine by Design Investigator. \n\n  \nRoshane Frances\, PhD Postdoctoral Research Fellow\, Keith Pardee lab\, Department of Pharmaceutical Sciences\, University of Toronto \nTCR-CAR T cells: Engineering immune cells to treat cancer \nRoshane Frances is a recent SickKids PhD graduate currently working as a post-doctoral fellow in Dr. Pardee’s Lab at the University of Toronto. During her PhD\, she explored how the embryonic stomach develops in mice and used these insights to study gastric cancer initiation. Wanting to explore more translation specific opportunities\, her post-doctoral studies involved engineering drug-secreting bacteria for the treatment of inflammatory bowel diseases and CAR T-cells to target colon cancer cells! \n\nAbout Conversations in Convergence\n\nThe goal is to foster cross-disciplinary discussions in support of convergence\, which is the integration of approaches from engineering\, science\, medicine and other fields to expand knowledge and spark innovation. The researchers will discuss how their unique perspectives\, knowledge and ideas inform their work\, and how their diverse approaches intersect and complement one another to advance regenerative medicine. \n 
URL:https://mbd.ccrm.ca/event/conversations-in-convergence-kristin-hope-phd-and-roshane-frances-phd/
LOCATION:Donnelly Centre for Cellular and Biomolecular Research\, Red Room\, 160 College Street\, Toronto\, Ontario\, M5S 3E1\, Canada
CATEGORIES:Other Events
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220706T143000
DTEND;TZID=America/Toronto:20220706T153000
DTSTAMP:20260405T165012
CREATED:20220615T184809Z
LAST-MODIFIED:20220622T143150Z
UID:17410-1657117800-1657121400@mbd.ccrm.ca
SUMMARY:Conversations in Convergence: Jesse Gillis\, PhD\, and Alaura Androschuk
DESCRIPTION:Note: We are excited to transition Conversations in Convergence from a virtual to an in-person event\, providing more opportunity for networking and potential collaboration.  \nJoin us for our Conversations in Convergence series\, which features interactive discussions between Medicine by Design researchers who study similar questions using different approaches. \nThe theme of this conversation will be\, “Immune modulation by extrinsic and environmental factors.” \nRegister now\n\nSpeakers \nAlaura Androschuk \, PhD candidate in Michael Sefton’s lab\, Institute of Biomedical Engineering and the Department of Chemical Engineering & Applied Chemistry. \nIdentifying signalling pathways underlying biomaterial-driven terminal axon growth using single nucleus RNA-sequencing \nAlaura Androschuk is a PhD candidate focusing on the use of biomaterials for endogenous repair of tissues\, specifically subcutaneous nerve regeneration. Under the supervision of  Michael Sefton\, she has focused in part on identifying the signalling pathways and cells underlying the biomaterial-driven repair of complex tissues using proteomics and single nucleus transcriptomics. \n\nJesse Gillis\, Associate Professor and Bassingthwaighte Chair in Integrative Physiology\, Department of Physiology\, University of Toronto. \nBuffered and unbuffered cell lineage variability \nJesse Gillis completed his undergraduate in Biophysics at the University of Toronto\, where he also received his PhD in Neuroscience in 2007. His post-doctoral training was done at the Centre for High-throughput Biology at UBC. There\, he focused on meta-analysis of expression data\, and particularly co-expression analysis\, which infers functionality between genes based on shared expression profiles\, a form of network analysis. Jesse joined the faculty of CSHL in 2012 with a central focus on improving network analysis. In 2017\, he was promoted to Associate Professor at CSHL with his work focusing on single cell analysis\, particularly in collaboration with researchers in the BRAIN Initiative Cell Census Network. In 2022\, Jesse returned to U of T as the inaugural Bassingthwaighte Chair in Integrative Physiology and a Medicine by Design investigator. \n\nAbout Conversations in Convergence\n\nThe goal is to foster cross-disciplinary discussions in support of convergence\, which is the integration of approaches from engineering\, science\, medicine and other fields to expand knowledge and spark innovation. The researchers will discuss how their unique perspectives\, knowledge and ideas inform their work\, and how their diverse approaches intersect and complement one another to advance regenerative medicine. \n 
URL:https://mbd.ccrm.ca/event/conversations-in-convergence-jessis-gillis-phd-and-alaura-androschuk/
LOCATION:Donnelly Centre for Cellular and Biomolecular Research\, Red Room\, 160 College Street\, Toronto\, Ontario\, M5S 3E1\, Canada
CATEGORIES:Other Events
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220406T100000
DTEND;TZID=America/Toronto:20220406T110000
DTSTAMP:20260405T165012
CREATED:20220317T202954Z
LAST-MODIFIED:20220322T155320Z
UID:16756-1649239200-1649242800@mbd.ccrm.ca
SUMMARY:Conversations in Convergence: Courtney Jones\, PhD and Sophie McGibbon-Gardner
DESCRIPTION:Join us for our Conversations in Convergence series which is an interactive discussions between Medicine by Design researchers who study similar questions using different approaches. \nThe goal is to foster cross-disciplinary discussions in support of convergence\, which is the integration of approaches from engineering\, science\, medicine and other fields to expand knowledge and spark innovation. The researchers will discuss how their unique perspectives\, knowledge and ideas inform their work\, and how their diverse approaches intersect and complement one another to advance regenerative medicine. \nOur speakers will be: \n\nCourtney Jones\, PhD – Scientist\, Princess Margaret Cancer Centre\, University Health Network and Assistant Professor\, Department of Medical Biophysics\, University of Toronto\nSophie McGibbon-Gardner – PhD Candidate\, Department of Physics\, University of Toronto\n\n\nEvent theme: Deciphering cancer heterogeneity and metabolomics using different approaches \nSpeaker Biographies: \nCourtney Jones is a Scientist at the Princess Margaret Cancer Centre\, University Health Network\, and Assistant Professor in the Dept. of Medical Biophysics at the University of Toronto. Professor Jones received her doctorate from New York University in 2014 studying mechanisms of therapy resistance in pediatric acute lymphoblastic leukemia. She continued her training as a postdoctoral fellow with Dr. Craig Jordan at the University of Colorado where she studied metabolic properties of leukemia stem cells (LSCs). \n  \n \nSophie is a PhD Candidate focusing on biophysics – particularly the dynamics of cells. She is from Nova Scotia\, where she completed her undergraduate degree in physics and discovered the power of using quantitative and computational approaches to better understand complex systems. As a PhD student\, she has used these approaches to identify underlying dynamics of cells when finding answers experimentally is difficult or impossible. She has focused on understanding heritable heterogeneity in cellular reprogramming and assessing the role of tumor cell fitness in cancer treatment. \n  \nRegister now
URL:https://mbd.ccrm.ca/event/conversations-in-convergence-courtney-jones-phd-and-sophie-mcgibbon-gardner-phd/
LOCATION:Ontario
CATEGORIES:Other Events
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220223T140000
DTEND;TZID=America/Toronto:20220223T150000
DTSTAMP:20260405T165012
CREATED:20220208T154915Z
LAST-MODIFIED:20220215T182045Z
UID:16469-1645624800-1645628400@mbd.ccrm.ca
SUMMARY:Conversations in Convergence: Julien Muffat\, PhD\, and Chao Wang\, PhD
DESCRIPTION:Join us for our Conversations in Convergence series which is an interactive discussions between Medicine by Design researchers who study similar questions using different approaches. \nThe goal is to foster cross-disciplinary discussions in support of convergence\, which is the integration of approaches from engineering\, science\, medicine and other fields to expand knowledge and spark innovation. The researchers will discuss how their unique perspectives\, knowledge and ideas inform their work\, and how their diverse approaches intersect and complement one another to advance regenerative medicine. \nOur speakers will be: \n\nJulien Muffat\, PhD – Scientist\, Neurosciences and Mental Health Program\, The Hospital for Sick Children and Assistant Professor\, Department of Molecular Genetics\, University of Toronto\nChao Wang\, PhD – Scientist\, Biological Sciences Platform\, Sunnybrook Research Institute and Assistant Professor\, Department of Immunology\, University of Toronto\n\n\nEvent theme: Role of immune cells in brain health \n  \nThe Muffat Lab studies how genetic and environmental vulnerabilities intersect to cause neurological disorders. We develop novel 3D cultures derived from human pluripotent stem cells\, to study degenerative and developmental diseases of the brain. We focus on inflammatory triggers\, including viral aetiologies\, in Autism\, Multiple Sclerosis or Alzheimer’s disease. Our work aims to highlight the dominant role of glial cells\, including resident immune cells such as the microglia\, in establishing neuronal dysfunction. The CRISPR toolkit allows functional interrogation of disease-associated variants expressed in specific cell types\, and unbiased genome-wide screens of cellular states and resilience. \n  \n \nChao Wang (PhD) is an immunologist with expertise in immune cell regulation\, cellular metabolism and single cell transcriptomics. As a postdoctoral fellow\, she discovered a role of CD5Like in regulating T lymphocyte function by promoting a polyunsaturated lipidome and regulating the ligand-dependent transcriptional activity of Rorgt (Cell\, 2015); she also uncovered and validated a T cell exhaustion/dysfunction module driven by zine metabolism in melanoma (Cell\, 2016). Based on these findings\, Dr. Wang validated a novel computational tool that allows comprehensive analysis of metabolism using single cell transcriptomics (Cell\, 2021). Leveraging such tools\, cell biology and animal modelling\, the Wang lab focuses on elucidating the molecular mechanisms of how cellular metabolic circuitry supports immune cell function in shaping neuroinflammation in autoimmune\, neurodegenerative and psychiatric disorders. \nRegister now
URL:https://mbd.ccrm.ca/event/conversations-in-convergence-julien-muffat-phd-and-chao-wang-phd/
LOCATION:Ontario
CATEGORIES:Other Events
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211111T140000
DTEND;TZID=America/Toronto:20211111T150000
DTSTAMP:20260405T165012
CREATED:20211103T185027Z
LAST-MODIFIED:20211108T163256Z
UID:15788-1636639200-1636642800@mbd.ccrm.ca
SUMMARY:Conversations in Convergence: Omar F. Khan\, PhD\, and Tharini Sivasubramaniyam\, PhD
DESCRIPTION:Join us for our Conversations in Convergence series which is an interactive discussions between Medicine by Design researchers who study similar questions using different approaches. \nThe goal is to foster cross-disciplinary discussions in support of convergence\, which is the integration of approaches from engineering\, science\, medicine and other fields to expand knowledge and spark innovation. The researchers will discuss how their unique perspectives\, knowledge and ideas inform their work\, and how their diverse approaches intersect and complement one another to advance regenerative medicine. \nOur speakers will be: \n\nOmar F. Khan\, PhD – Assistant Professor\, Institute of Biomedical Engineering and Department of Immunology\, University of Toronto and Medicine by Design\, Investigator\nTharini Sivasubramaniyam\, PhD –Post-Doctoral Fellow\, Clinton Robbins Lab\, Toronto General Hospital Research Institute\, University Health Network\n\nRegister now\n \nProfessor Khan earned his B.A.Sc. and Ph.D. in Chemical Engineering and Applied Chemistry from the University of Toronto\, and his academic supervisor was Professor Michael V. Sefton. He later joined the laboratories of Professors Daniel G. Anderson and Robert Langer as a Postdoctoral Associate in the Massachusetts Institute of Technology. Professor Khan is also the Scientific Founder and former Chief Scientist of Tiba Biotech\, a Boston-area company spun out from his postdoctoral research. As an mRNA nanotechnology and vaccine expert\, he is regularly featured in television\, radio and print news. His early career focused on the creation of three dimensional organoid models and engineered tissue substitutes. This work evolved to include the development of nucleic acid-based platform technologies and novel biomaterials to study the genetic mechanisms of diseases and create RNA-based therapies. Now\, Professor Khan endeavors to contribute to Canada’s growing research-to-translation ecosystem by creating new regenerative medicine-enabling technologies\, and training highly qualified personnel capable of addressing diverse local and global bioengineering needs. \n  \nTharini completed her BSc\, MSc and PhD at University of Toronto. Her MSc was under the supervision of Dr. Isabella Caniggia where she assessed the role of Par6\, a key regulator of cell polarity\, during normal human placental development and in preeclampsia. She shifted gears and went on and completed her PhD under Dr. Minna Woo where she investigated how hepatic signaling affects atherosclerosis in vivo. During this time\, she was the recipient of many prestigious awards including Frederick Banting and Charles Best Canada Graduate Scholarships Doctoral Award\, Canadian Liver Foundation Graduate Studentship\, and Canadian Diabetes Association Doctoral Student Research Award. Wanting to broaden her knowledge in immunology she joined the laboratory of Dr. Clinton Robbins as a postdoctoral fellow where she is tackling major unmet biomedical questions in understanding how tissue microenvironments affect the function of immune cells.
URL:https://mbd.ccrm.ca/event/conversations-in-convergence-omar-khan-phd-and-thara-sivasubramaniyam-phd/
LOCATION:Ontario
CATEGORIES:Other Events
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20210507T100000
DTEND;TZID=America/Toronto:20210507T110000
DTSTAMP:20260405T165012
CREATED:20210419T161645Z
LAST-MODIFIED:20210507T143446Z
UID:13651-1620381600-1620385200@mbd.ccrm.ca
SUMMARY:Grand Questions: Glimpse the future of regenerative medicine
DESCRIPTION:Please use event link: https://www.youtube.com/watch?v=gzZw6yeGYLU. \nLast year\, Medicine by Design challenged its researchers to think boldly about how they would solve regenerative medicine’s grand questions such as how to create tissues that outperform nature to resist novel infections or cancer or how to make regenerative medicine affordable and accessible to everyone. Now\, we are investing $3 million in some of their most ambitious ideas with the ultimate goal of preparing the foundation for the future of human health. \nRegister now\nAt the event\n\n10 a.m. – Greetings from Christine Allen\nAssociate Vice-President and Vice-Provost\, Strategic Initiatives\, University of Toronto and Professor\, Leslie Dan Faculty of Pharmacy\n10:05 a.m. – Announcement of Grand Questions funded projects\nMeet the extraordinary Grand Questions teams that will help make regenerative medicine solutions a reality for all disease.\n10:10 a.m. – Panel discussion\n“Ambitious and provocative – expanding the frontiers of regenerative medicine”\nModerated by Janet Rossant\, President and Scientific Director\, The Gairdner Foundation and Chief of Research Emeritus\, SickKids Research Institute.\nThis interactive panel discussion will focus on why ambitious\, provocative and non-obvious solutions are the future of regenerative medicine.
URL:https://mbd.ccrm.ca/event/grand-questions-glimpse-the-future-of-regenerative-medicine/
LOCATION:Ontario
CATEGORIES:Other Events
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20210428T100000
DTEND;TZID=America/Toronto:20210428T110000
DTSTAMP:20260405T165012
CREATED:20210401T161249Z
LAST-MODIFIED:20210407T012959Z
UID:13394-1619604000-1619607600@mbd.ccrm.ca
SUMMARY:Conversations in Convergence: Stephanie Protze\, PhD\, and Eric Strohm\, PhD
DESCRIPTION:Join us for our Conversations in Convergence series which is an interactive discussions between Medicine by Design researchers who study similar questions using different approaches. \nThe goal is to foster cross-disciplinary discussions in support of convergence\, which is the integration of approaches from engineering\, science\, medicine and other fields to expand knowledge and spark innovation. The researchers will discuss how their unique perspectives\, knowledge and ideas inform their work\, and how their diverse approaches intersect and complement one another to advance regenerative medicine. \nOur speakers will be: \n\nStephanie Protze\, PhD – Principal Investigator\, McEwen Stem Cell Institute\, at the University Health Network and Assistant Professor\, Department of Molecular Genetics\, University of Toronto\nEric Strohm\, PhD – Post-Doctoral Fellow\, Craig Simmons Cellular Mechanobiology Lab\, Department of Mechanical and Industrial Engineering\, University of Toronto\n\nRegister Now\n \nDr. Protze studies how the human heart develops with a specific focus the cardiac conduction system that regulates the heartbeat. Her lab uses pluripotent stem cells\, single cell transcriptomics\, and electrophysiology assays to study heart development and diseases in a petri-dish. In addition\, her team explores the application of the stem cell-derived conduction system cells in cell therapy approaches to treat heart rhythm disorders. \n  \nDr. Strohm post-doctoral fellow work uses microscale ultrasound to measure the contractile forces of cardiomyocyte cells and tissues. Using a custom-built system\, the contractions are rapidly measured using ultrasound with sub-micrometer precision to determine the forces exerted. The system is highly versatile and can measure cell contractility in a range of platforms\, including standard cell culture plates and specialized heart-on-a-chip systems. Applications include evaluating drug cardiotoxicity\, screening drug candidates to treat heart failure\, and quantifying stem cell-based therapies for regenerative cardiac repair.
URL:https://mbd.ccrm.ca/event/conversations-in-convergence-stephanie-protze-phd-and-eric-strohm-phd/
LOCATION:Ontario
CATEGORIES:Other Events
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20210210T110000
DTEND;TZID=America/Toronto:20210210T120000
DTSTAMP:20260405T165012
CREATED:20210201T142350Z
LAST-MODIFIED:20210429T141611Z
UID:12330-1612954800-1612958400@mbd.ccrm.ca
SUMMARY:Conversations in Convergence: Yun Li\, PhD\, and Erica Scott\, PhD
DESCRIPTION:Join us for our first edition of Conversations in Convergence\, a series of interactive discussions between Medicine by Design researchers who study similar questions using different approaches. \nOur first speakers will be: \n\nYun Li\, PhD – Scientist\, Developmental & Stem Cell Biology\, The Hospital for Sick Children; Assistant Professor\, Department of Molecular Genetics\, University of Toronto; and Medicine by Design Investigator \nErica Scott\, PhD – Post-Doctoral Fellow\, Wheeler Microfluidics Lab\, Department of Chemistry and Institute of Biomaterials & Biomedical Engineering\, University of Toronto; and 2018 Medicine by Design Post-Doctoral Fellowship award winner  \n\n \nDr. Li studies how the human brain is formed\, what makes the human brain different from that of the other species\, and how disorders such as autism impact its normal development and function. She uses pluripotent stem cell\, genome editing\, and 3-dimensional organoid technologies to study brain development in a dish.  \nIn Dr. Scott’s post-doctoral fellowship\, she is developing a tool to analyze neural stem cell networks at single-cell resolution. This tool combines a single cell laser lysis technique\, microfluidics and RNA and DNA sequencing. Dr. Scott aims to describe the high degree of variability between neural stem cells and their environment to best harness their therapeutic potential.  \n\nThe goal of Conversations in Convergence is to foster cross-disciplinary discussions in support of convergence\, which is the integration of approaches from engineering\, science\, medicine and other fields to expand knowledge and spark innovation. The researchers will discuss how their unique perspectives\, knowledge and ideas inform their work\, and how their diverse approaches intersect and complement one another to advance regenerative medicine.  \nRegister now\n 
URL:https://mbd.ccrm.ca/event/conversations-in-convergence-february-2020/
LOCATION:Ontario
CATEGORIES:Other Events
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20201112T120000
DTEND;TZID=America/Toronto:20201112T133000
DTSTAMP:20260405T165012
CREATED:20201102T192657Z
LAST-MODIFIED:20201229T204130Z
UID:10392-1605182400-1605187800@mbd.ccrm.ca
SUMMARY:Medicine by Design Healthy and Inclusive Labs: Manu Platt\, PhD\, and Anita Balakrishna\, LLB
DESCRIPTION:Theme of this talk: Bridging the racial divide in society and academia\nMedicine by Design Healthy and Inclusive Labs Committee invites you to join us for this interactive discussion with Associate Professor Manu Platt\, PhD\, Wallace H. Coulter Department of Biomedical Engineering at the Georgia Institute of Technology\, and Emory University and Anita Balakrishna\, LLB\, Director\, Equity\, Diversity & Inclusion\, Temerty Faculty of Medicine\, U of T about bridging the racial divide in society and academia. \nThis is the first in a series of events offered by Medicine by Design’s Healthy and Inclusive Labs Committee. These events will create opportunities for the Medicine by Design Community to engage in conversations about the importance of equity\, diversity and inclusion in innovation; systemic racism; unconscious bias; barriers to inclusion in the academy; and much more. The goal is to spark change in our labs\, our community\, and in STEM more broadly. \nClick HERE to register for this virtual event. \n  \n \nManu Platt\nManu Platt received his BS in biology from Morehouse College in 2001 and his PhD from the Georgia Tech and Emory joint program in biomedical engineering in 2006. He finished his post-doctoral training at MIT in orthopedic tissue engineering and systems biology prior to returning to Georgia Tech and Emory’s Joint Department of Biomedical Engineering in 2009\, where he has since been promoted and tenured. His research centers on proteolytic mechanisms of tissue remodeling during disease progression using both experimental and computational approaches. \nIntegrated with his research program is his mentoring goal of changing the look of the next generation of scientists and engineers to include all colours\, genders\, and backgrounds. Aligned with that goal\, Dr. Platt\, along with Bob Nerem\, co-founded and co-directs Project ENGAGES (Engaging the Next Generation At Georgia Tech in Engineering and Science)\, a program paying African-American high school students from Atlanta Public Schools to be researchers in Georgia Tech labs since 2013. \n  \n \nAnita Balakrishna\nAnita Balakrishna is currently serving as the Director\, Equity\, Diversity and Inclusion at the University of Toronto Faculty of Medicine. Anita is a lawyer and educator with a human rights background. She has focused on a social justice based practice\, providing legal advocacy\, education\, and law reform activities alongside low-income and other underserved communities through her work at the Human Rights Legal Support Centre\, the South Asian Legal Clinic of Ontario and the Rexdale Community Legal Clinic. \nEvent Agenda\n\n12:00pm – 12:05pm Welcoming Remarks  – Molly Shoichet\n12:05pm – 12:15pm Introduction Presentation – Anita Balakrishna\n12:15pm – 1:00pm Presentation – Manu Platt\n1:00pm – 1:25pm Panel Discussion – Manu Platt and Anita Balakrishna (Moderated by Molly Shoichet)\n1:25pm – 1:30pm Closing Remarks – Molly Shoichet
URL:https://mbd.ccrm.ca/event/bridging-the-racial-divide/
LOCATION:Virtual
CATEGORIES:Other Events
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20190723T110000
DTEND;TZID=America/Toronto:20190723T120000
DTSTAMP:20260405T165012
CREATED:20190716T183334Z
LAST-MODIFIED:20191125T194316Z
UID:6804-1563879600-1563883200@mbd.ccrm.ca
SUMMARY:Translational Biology & Engineering Program Research Seminar: Shulamit Levenberg\, PhD\, Technion
DESCRIPTION:Professor Shulamit Levenberg\, PhD\, Dean of the Faculty of Biomedical Engineering at Technion-Israel Institute of Technology will give a talk titled “Engineered vascularized tissue constructs.” \n\nLearn more
URL:https://mbd.ccrm.ca/event/translational-biology-engineering-program-research-seminar-shulamit-levenberg-phd-technion/
LOCATION:Ted Rogers Centre for Heart Research\, 661 University Avenue\, 14th Floor\, Toronto\, Ontario\, M5G 1M1\, Canada
CATEGORIES:Other Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20190401T150000
DTEND;TZID=America/Toronto:20190401T160000
DTSTAMP:20260405T165012
CREATED:20190329T205705Z
LAST-MODIFIED:20191126T154243Z
UID:6521-1554130800-1554134400@mbd.ccrm.ca
SUMMARY:Special Seminar: Dr. Timothy O'Brien\, National University of Ireland\, Galway
DESCRIPTION:Timothy O’Brien\, MD\, PhD will give a talk titled “Therapeutic Potential of Mesenchymal Stem Cells for Diabetic Complications: Translational Pathway in the EU.” \n\nDownload poster\n\nAbstract\nDiabetes mellitus is assuming pandemic proportions and is associated with microvascular and macrovascular complications which result in major morbidity and mortality. These conditions represent unmet medical need and new treatment approaches are needed. My laboratory is interested in the use of mesenchymal stromal cells to treat diabetic complications as they are readily isolated\, can be culture expanded under GMP conditions and possess anti-inflammatory\, immunomodulatory and angiogenic properties. We are particularly interested in the translation of laboratory discoveries to the clinic and to this end have constructed specialized GMP and clinical research facilities. The presentation will describe the translational pathway\, with an emphasis on regulatory issues\, in progressing from the laboratory to early phase clinical trials. Pre-clinical and early clinical trial experience of the use of MSCs in diabetic macrovascular and microvascular disease will be presented. Advances in cell manufacture will also be described. \nBiography\nDr. O’Brien is Professor of Medicine and Director of the Regenerative Medicine Institute\, National University of Ireland Galway. He is also a Consultant Physician in Endocrinology and Metabolism\, Saolta University Healthcare Group\, Ireland.
URL:https://mbd.ccrm.ca/event/special-seminar-dr-timothy-obrien-national-university-of-ireland-galway/
LOCATION:Ted Rogers Centre for Heart Research\, 661 University Avenue\, 14th Floor\, Toronto\, Ontario\, M5G 1M1\, Canada
CATEGORIES:Other Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20190121T150000
DTEND;TZID=America/Toronto:20190121T160000
DTSTAMP:20260405T165012
CREATED:20190116T151320Z
LAST-MODIFIED:20191125T194331Z
UID:6332-1548082800-1548086400@mbd.ccrm.ca
SUMMARY:Special Seminar: Kaitlyn Sadtler\, PhD
DESCRIPTION:The Institute of Biomaterials & Biomedical Engineering and Medicine by Design present a special seminar by Kaitlyn Sadtler\, PhD. The title of her talk is “Harnessing the Immune System in Regenerative Medicine.” Learn more
URL:https://mbd.ccrm.ca/event/special-seminar-kaitlyn-sadtler-phd/
LOCATION:Canada
CATEGORIES:Other Events
END:VEVENT
END:VCALENDAR